These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32612666)

  • 1. SARS-CoV-2 disease severity and diabetes: why the connection and what is to be done?
    Mazucanti CH; Egan JM
    Immun Ageing; 2020; 17():21. PubMed ID: 32612666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
    Valencia I; Peiró C; Lorenzo Ó; Sánchez-Ferrer CF; Eckel J; Romacho T
    Front Pharmacol; 2020; 11():1161. PubMed ID: 32848769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 and diabetes mellitus: Unraveling the hypotheses that worsen the prognosis (Review).
    Albulescu R; Dima SO; Florea IR; Lixandru D; Serban AM; Aspritoiu VM; Tanase C; Popescu I; Ferber S
    Exp Ther Med; 2020 Dec; 20(6):194. PubMed ID: 33101484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of COVID-19, SARS and MERS.
    Hu T; Liu Y; Zhao M; Zhuang Q; Xu L; He Q
    PeerJ; 2020; 8():e9725. PubMed ID: 32879801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The underlying mechanisms for severe COVID-19 progression in people with diabetes mellitus: a critical review.
    Figueroa-Pizano MD; Campa-Mada AC; Carvajal-Millan E; Martinez-Robinson KG; Chu AR
    AIMS Public Health; 2021; 8(4):720-742. PubMed ID: 34786431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association of Cardiovascular Diseases and Diabetes Mellitus with COVID-19 (SARS-CoV-2) and Their Possible Mechanisms.
    Roy S; Mazumder T; Banik S
    SN Compr Clin Med; 2020; 2(8):1077-1082. PubMed ID: 32838148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation Between CT Severity Scoring and Diabetes Mellitus in Patients With COVID-19 Infection.
    Rangankar V; Koganti DV; Lamghare P; Prabhu A; Dhulipala S; Patil P; Yadav P
    Cureus; 2021 Dec; 13(12):e20199. PubMed ID: 35004020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy for ANCA-associated vasculitis during the COVID-19 pandemic.
    Gapud EJ; Kronbichler A; Gauckler P; Geetha D
    Eur J Rheumatol; 2020 Aug; 7(Suppl 2):S121-S128. PubMed ID: 32716836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and epidemiological features of COVID-19 deaths in Nepal.
    Panthee B; Dhungana S; Panthee N; Gyawali S; Paudel A; Panthee S
    New Microbes New Infect; 2020 Nov; 38():100797. PubMed ID: 33101695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis on the role of pre-existing chronic disease in the cardiac complications of SARS-CoV-2 infection.
    Sinclair JE; Zhu Y; Xu G; Ma W; Shi H; Ma KL; Cao CF; Kong LX; Wan KQ; Liao J; Wang HQ; Arentz M; Redd MA; Gallo LA; Short KR
    iScience; 2021 Apr; 24(4):102264. PubMed ID: 33688629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association among Lifestyle and Risk Factors with SARS-CoV-2 Infection.
    Ko Y; Ngai ZN; Koh RY; Chye SM
    Tuberc Respir Dis (Seoul); 2023 Apr; 86(2):102-110. PubMed ID: 36597582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophages in diabetes mellitus (DM) and COVID-19: do they trigger DM?
    Kloc M; Ghobrial RM; Lewicki S; Kubiak JZ
    J Diabetes Metab Disord; 2020 Dec; 19(2):2045-2048. PubMed ID: 33102261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes Mellitus after SARS-CoV-2 Infection: An Epidemiological Review.
    Ilic I; Ilic M
    Life (Basel); 2023 May; 13(6):. PubMed ID: 37374016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes, Heart Failure, and COVID-19: An Update.
    Hebbard C; Lee B; Katare R; Garikipati VNS
    Front Physiol; 2021; 12():706185. PubMed ID: 34721055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes Mellitus-A Risk Factor for Unfavourable Outcome in COVID-19 Patients-The Experience of an Infectious Diseases Regional Hospital.
    Miftode E; Miftode L; Coman I; Prepeliuc C; Obreja M; Stămăteanu O; Părângă TG; Leca D; Pleşca CE
    Healthcare (Basel); 2021 Jun; 9(7):. PubMed ID: 34201473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment and Management of Diabetic Patients During the COVID-19 Pandemic.
    Verma AK; Beg MMA; Bhatt D; Dev K; Alsahli MA; Rahmani AH; Goyal Y
    Diabetes Metab Syndr Obes; 2021; 14():3131-3146. PubMed ID: 34262317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New-Onset Diabetes Mellitus Presenting As Diabetic Ketoacidosis in Patients With COVID-19: A Case Series.
    Sarwani A; Al Saeed M; Taha H; Al Fardan RM
    Cureus; 2021 Jul; 13(7):e16290. PubMed ID: 34381649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and COVID-19: what makes obese host so vulnerable?
    Mohammad S; Aziz R; Al Mahri S; Malik SS; Haji E; Khan AH; Khatlani TS; Bouchama A
    Immun Ageing; 2021 Jan; 18(1):1. PubMed ID: 33390183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Critical Review on the Long-Term COVID-19 Impacts on Patients With Diabetes.
    Ashique S; Mishra N; Garg A; Garg S; Farid A; Rai S; Gupta G; Dua K; Paudel KR; Taghizadeh-Hesary F
    Am J Med; 2024 Mar; ():. PubMed ID: 38485111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New thoughts on the diagnosis and treatment of patients with diabetes mellitus in relation to coronavirus disease.
    Lou XQ; Wang DW; Wang JF; Du B
    World J Diabetes; 2020 Nov; 11(11):481-488. PubMed ID: 33269060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.